Medivir AB (publ) (STO: MVIR)
Sweden
· Delayed Price · Currency is SEK
2.820
-0.070 (-2.42%)
At close: Jan 29, 2025
Medivir AB Revenue
Medivir AB had revenue of 900.00K SEK in the quarter ending September 30, 2024, with 12.50% growth. This brings the company's revenue in the last twelve months to 7.03M, up 27.69% year-over-year. In the year 2023, Medivir AB had annual revenue of 7.63M with 73.16% growth.
Revenue (ttm)
7.03M
Revenue Growth
+27.69%
P/S Ratio
41.99
Revenue / Employee
703.30K
Employees
10
Market Cap
319.68M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.63M | 3.23M | 73.16% |
Dec 31, 2022 | 4.41M | -27.99M | -86.39% |
Dec 31, 2021 | 32.39M | 11.96M | 58.56% |
Dec 31, 2020 | 20.43M | 11.71M | 134.18% |
Dec 31, 2019 | 8.72M | -15.14M | -63.44% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 25.44B |
Getinge AB | 34.76B |
Sectra AB | 3.14B |
Camurus AB | 1.69B |
Vitrolife AB | 3.61B |
Medicover AB | 22.60B |
Elekta AB | 17.72B |
Bonesupport Holding AB | 814.46M |